nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0417	0.0879	CbGbCtD
Alfuzosin—CYP3A4—Trimethadione—epilepsy syndrome	0.0388	0.0817	CbGbCtD
Alfuzosin—CYP3A4—Felbamate—epilepsy syndrome	0.0388	0.0817	CbGbCtD
Alfuzosin—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0365	0.0768	CbGbCtD
Alfuzosin—CYP3A4—Clonazepam—epilepsy syndrome	0.033	0.0694	CbGbCtD
Alfuzosin—CYP3A4—Clobazam—epilepsy syndrome	0.0316	0.0666	CbGbCtD
Alfuzosin—CYP3A4—Rufinamide—epilepsy syndrome	0.0269	0.0566	CbGbCtD
Alfuzosin—CYP3A4—Carbamazepine—epilepsy syndrome	0.0262	0.0552	CbGbCtD
Alfuzosin—CYP3A4—Primidone—epilepsy syndrome	0.0245	0.0515	CbGbCtD
Alfuzosin—CYP3A4—Phenytoin—epilepsy syndrome	0.0235	0.0495	CbGbCtD
Alfuzosin—CYP3A4—Propofol—epilepsy syndrome	0.0219	0.0462	CbGbCtD
Alfuzosin—CYP3A4—Phenobarbital—epilepsy syndrome	0.021	0.0441	CbGbCtD
Alfuzosin—CYP3A4—Acetazolamide—epilepsy syndrome	0.021	0.0441	CbGbCtD
Alfuzosin—CYP3A4—Midazolam—epilepsy syndrome	0.0207	0.0435	CbGbCtD
Alfuzosin—CYP3A4—Diazepam—epilepsy syndrome	0.0199	0.0418	CbGbCtD
Alfuzosin—CYP3A4—Zonisamide—epilepsy syndrome	0.0194	0.0408	CbGbCtD
Alfuzosin—CYP3A4—Valproic Acid—epilepsy syndrome	0.0157	0.033	CbGbCtD
Alfuzosin—CYP3A4—Topiramate—epilepsy syndrome	0.0141	0.0297	CbGbCtD
Alfuzosin—ADRA1A—hindbrain—epilepsy syndrome	0.00123	0.0728	CbGeAlD
Alfuzosin—ADRA1D—forebrain—epilepsy syndrome	0.00118	0.0701	CbGeAlD
Alfuzosin—Doxazosin—ADRA2A—epilepsy syndrome	0.00113	0.189	CrCbGaD
Alfuzosin—ADRA1D—telencephalon—epilepsy syndrome	0.00109	0.0645	CbGeAlD
Alfuzosin—Prazosin—ADRA2A—epilepsy syndrome	0.00104	0.175	CrCbGaD
Alfuzosin—Prazosin—ABCG2—epilepsy syndrome	0.00096	0.161	CrCbGaD
Alfuzosin—Doxazosin—CYP2C19—epilepsy syndrome	0.000819	0.137	CrCbGaD
Alfuzosin—ADRA1A—brainstem—epilepsy syndrome	0.000704	0.0417	CbGeAlD
Alfuzosin—ADRA1B—head—epilepsy syndrome	0.000693	0.041	CbGeAlD
Alfuzosin—ADRA1A—forebrain—epilepsy syndrome	0.00068	0.0403	CbGeAlD
Alfuzosin—ADRA1D—head—epilepsy syndrome	0.000678	0.0402	CbGeAlD
Alfuzosin—ADRA1B—nervous system—epilepsy syndrome	0.000657	0.0389	CbGeAlD
Alfuzosin—KCNH2—forebrain—epilepsy syndrome	0.000657	0.0389	CbGeAlD
Alfuzosin—ADRA1D—nervous system—epilepsy syndrome	0.000643	0.0381	CbGeAlD
Alfuzosin—ADRA1B—central nervous system—epilepsy syndrome	0.000633	0.0375	CbGeAlD
Alfuzosin—ADRA1A—telencephalon—epilepsy syndrome	0.000625	0.037	CbGeAlD
Alfuzosin—ADRA1D—central nervous system—epilepsy syndrome	0.000619	0.0366	CbGeAlD
Alfuzosin—Doxazosin—CYP2D6—epilepsy syndrome	0.000607	0.102	CrCbGaD
Alfuzosin—KCNH2—telencephalon—epilepsy syndrome	0.000604	0.0358	CbGeAlD
Alfuzosin—Terazosin—ABCB1—epilepsy syndrome	0.000583	0.0975	CrCbGaD
Alfuzosin—ADRA1B—brain—epilepsy syndrome	0.000502	0.0297	CbGeAlD
Alfuzosin—ADRA1D—brain—epilepsy syndrome	0.000491	0.0291	CbGeAlD
Alfuzosin—KCNH2—medulla oblongata—epilepsy syndrome	0.000474	0.0281	CbGeAlD
Alfuzosin—Doxazosin—ABCB1—epilepsy syndrome	0.000434	0.0725	CrCbGaD
Alfuzosin—KCNH2—midbrain—epilepsy syndrome	0.000434	0.0257	CbGeAlD
Alfuzosin—KCNH2—spinal cord—epilepsy syndrome	0.000423	0.0251	CbGeAlD
Alfuzosin—Prazosin—ABCB1—epilepsy syndrome	0.0004	0.0668	CrCbGaD
Alfuzosin—ADRA1A—head—epilepsy syndrome	0.000389	0.0231	CbGeAlD
Alfuzosin—KCNH2—head—epilepsy syndrome	0.000376	0.0223	CbGeAlD
Alfuzosin—ADRA1A—nervous system—epilepsy syndrome	0.000369	0.0219	CbGeAlD
Alfuzosin—KCNH2—nervous system—epilepsy syndrome	0.000356	0.0211	CbGeAlD
Alfuzosin—ADRA1A—central nervous system—epilepsy syndrome	0.000355	0.021	CbGeAlD
Alfuzosin—ADRA1A—cerebellum—epilepsy syndrome	0.000347	0.0206	CbGeAlD
Alfuzosin—KCNH2—central nervous system—epilepsy syndrome	0.000343	0.0203	CbGeAlD
Alfuzosin—KCNH2—cerebellum—epilepsy syndrome	0.000335	0.0199	CbGeAlD
Alfuzosin—ADRA1A—brain—epilepsy syndrome	0.000282	0.0167	CbGeAlD
Alfuzosin—KCNH2—brain—epilepsy syndrome	0.000272	0.0161	CbGeAlD
Alfuzosin—CYP3A4—nervous system—epilepsy syndrome	0.000221	0.0131	CbGeAlD
Alfuzosin—CYP3A4—central nervous system—epilepsy syndrome	0.000213	0.0126	CbGeAlD
Alfuzosin—Sinusitis—Topiramate—epilepsy syndrome	0.000168	0.000494	CcSEcCtD
Alfuzosin—Rash—Levetiracetam—epilepsy syndrome	0.000168	0.000493	CcSEcCtD
Alfuzosin—Dermatitis—Levetiracetam—epilepsy syndrome	0.000167	0.000493	CcSEcCtD
Alfuzosin—Asthenia—Zonisamide—epilepsy syndrome	0.000167	0.000493	CcSEcCtD
Alfuzosin—Mental disorder—Gabapentin—epilepsy syndrome	0.000167	0.000492	CcSEcCtD
Alfuzosin—Dry mouth—Valproic Acid—epilepsy syndrome	0.000167	0.000491	CcSEcCtD
Alfuzosin—Headache—Levetiracetam—epilepsy syndrome	0.000166	0.00049	CcSEcCtD
Alfuzosin—Angioedema—Pregabalin—epilepsy syndrome	0.000166	0.000488	CcSEcCtD
Alfuzosin—Dizziness—Vigabatrin—epilepsy syndrome	0.000165	0.000487	CcSEcCtD
Alfuzosin—Pruritus—Zonisamide—epilepsy syndrome	0.000165	0.000486	CcSEcCtD
Alfuzosin—Oedema—Valproic Acid—epilepsy syndrome	0.000164	0.000482	CcSEcCtD
Alfuzosin—Urticaria—Lamotrigine—epilepsy syndrome	0.000164	0.000482	CcSEcCtD
Alfuzosin—Malaise—Pregabalin—epilepsy syndrome	0.000163	0.000481	CcSEcCtD
Alfuzosin—Nausea—Propofol—epilepsy syndrome	0.000163	0.000481	CcSEcCtD
Alfuzosin—Vomiting—Fosphenytoin—epilepsy syndrome	0.000163	0.00048	CcSEcCtD
Alfuzosin—Diarrhoea—Felbamate—epilepsy syndrome	0.000163	0.00048	CcSEcCtD
Alfuzosin—Vertigo—Pregabalin—epilepsy syndrome	0.000163	0.000479	CcSEcCtD
Alfuzosin—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000163	0.000479	CcSEcCtD
Alfuzosin—Dizziness—Diazepam—epilepsy syndrome	0.000163	0.000479	CcSEcCtD
Alfuzosin—Infection—Valproic Acid—epilepsy syndrome	0.000163	0.000479	CcSEcCtD
Alfuzosin—Syncope—Pregabalin—epilepsy syndrome	0.000163	0.000479	CcSEcCtD
Alfuzosin—Rash—Fosphenytoin—epilepsy syndrome	0.000162	0.000476	CcSEcCtD
Alfuzosin—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000162	0.000476	CcSEcCtD
Alfuzosin—Asthenia—Clonazepam—epilepsy syndrome	0.000161	0.000475	CcSEcCtD
Alfuzosin—Rhinitis—Topiramate—epilepsy syndrome	0.000161	0.000474	CcSEcCtD
Alfuzosin—Back pain—Gabapentin—epilepsy syndrome	0.000161	0.000473	CcSEcCtD
Alfuzosin—Headache—Fosphenytoin—epilepsy syndrome	0.000161	0.000473	CcSEcCtD
Alfuzosin—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.00016	0.000472	CcSEcCtD
Alfuzosin—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.00016	0.000472	CcSEcCtD
Alfuzosin—Palpitations—Pregabalin—epilepsy syndrome	0.00016	0.000472	CcSEcCtD
Alfuzosin—Asthenia—Phenytoin—epilepsy syndrome	0.00016	0.000472	CcSEcCtD
Alfuzosin—Nausea—Midazolam—epilepsy syndrome	0.00016	0.000471	CcSEcCtD
Alfuzosin—Tachycardia—Valproic Acid—epilepsy syndrome	0.00016	0.00047	CcSEcCtD
Alfuzosin—Diarrhoea—Zonisamide—epilepsy syndrome	0.00016	0.00047	CcSEcCtD
Alfuzosin—Pharyngitis—Topiramate—epilepsy syndrome	0.000159	0.000469	CcSEcCtD
Alfuzosin—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000159	0.000469	CcSEcCtD
Alfuzosin—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000159	0.000469	CcSEcCtD
Alfuzosin—Pruritus—Clonazepam—epilepsy syndrome	0.000159	0.000468	CcSEcCtD
Alfuzosin—Vomiting—Vigabatrin—epilepsy syndrome	0.000159	0.000468	CcSEcCtD
Alfuzosin—Skin disorder—Valproic Acid—epilepsy syndrome	0.000159	0.000468	CcSEcCtD
Alfuzosin—Urinary tract disorder—Topiramate—epilepsy syndrome	0.000159	0.000467	CcSEcCtD
Alfuzosin—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000158	0.000466	CcSEcCtD
Alfuzosin—Pruritus—Phenytoin—epilepsy syndrome	0.000158	0.000465	CcSEcCtD
Alfuzosin—Connective tissue disorder—Topiramate—epilepsy syndrome	0.000158	0.000465	CcSEcCtD
Alfuzosin—Nausea—Levetiracetam—epilepsy syndrome	0.000158	0.000465	CcSEcCtD
Alfuzosin—Rash—Vigabatrin—epilepsy syndrome	0.000158	0.000464	CcSEcCtD
Alfuzosin—Dizziness—Felbamate—epilepsy syndrome	0.000158	0.000464	CcSEcCtD
Alfuzosin—Dermatitis—Vigabatrin—epilepsy syndrome	0.000157	0.000464	CcSEcCtD
Alfuzosin—Urethral disorder—Topiramate—epilepsy syndrome	0.000157	0.000464	CcSEcCtD
Alfuzosin—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000157	0.000462	CcSEcCtD
Alfuzosin—Headache—Vigabatrin—epilepsy syndrome	0.000157	0.000461	CcSEcCtD
Alfuzosin—Vomiting—Diazepam—epilepsy syndrome	0.000157	0.000461	CcSEcCtD
Alfuzosin—Rash—Diazepam—epilepsy syndrome	0.000155	0.000457	CcSEcCtD
Alfuzosin—Dermatitis—Diazepam—epilepsy syndrome	0.000155	0.000456	CcSEcCtD
Alfuzosin—Arthralgia—Pregabalin—epilepsy syndrome	0.000154	0.000454	CcSEcCtD
Alfuzosin—Chest pain—Pregabalin—epilepsy syndrome	0.000154	0.000454	CcSEcCtD
Alfuzosin—Ill-defined disorder—Gabapentin—epilepsy syndrome	0.000154	0.000454	CcSEcCtD
Alfuzosin—Dizziness—Zonisamide—epilepsy syndrome	0.000154	0.000454	CcSEcCtD
Alfuzosin—Headache—Diazepam—epilepsy syndrome	0.000154	0.000454	CcSEcCtD
Alfuzosin—Diarrhoea—Clonazepam—epilepsy syndrome	0.000154	0.000453	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000153	0.000451	CcSEcCtD
Alfuzosin—Hypotension—Valproic Acid—epilepsy syndrome	0.000153	0.00045	CcSEcCtD
Alfuzosin—Asthenia—Carbamazepine—epilepsy syndrome	0.000153	0.00045	CcSEcCtD
Alfuzosin—Diarrhoea—Phenytoin—epilepsy syndrome	0.000153	0.00045	CcSEcCtD
Alfuzosin—Discomfort—Pregabalin—epilepsy syndrome	0.000152	0.000449	CcSEcCtD
Alfuzosin—Nausea—Fosphenytoin—epilepsy syndrome	0.000152	0.000449	CcSEcCtD
Alfuzosin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000152	0.000447	CcSEcCtD
Alfuzosin—Angioedema—Gabapentin—epilepsy syndrome	0.000152	0.000447	CcSEcCtD
Alfuzosin—Vomiting—Felbamate—epilepsy syndrome	0.000151	0.000446	CcSEcCtD
Alfuzosin—Dry mouth—Pregabalin—epilepsy syndrome	0.000151	0.000444	CcSEcCtD
Alfuzosin—Pruritus—Carbamazepine—epilepsy syndrome	0.000151	0.000444	CcSEcCtD
Alfuzosin—Rash—Felbamate—epilepsy syndrome	0.00015	0.000442	CcSEcCtD
Alfuzosin—Eye disorder—Topiramate—epilepsy syndrome	0.00015	0.000442	CcSEcCtD
Alfuzosin—Dermatitis—Felbamate—epilepsy syndrome	0.00015	0.000442	CcSEcCtD
Alfuzosin—Malaise—Gabapentin—epilepsy syndrome	0.00015	0.000441	CcSEcCtD
Alfuzosin—Vertigo—Gabapentin—epilepsy syndrome	0.000149	0.00044	CcSEcCtD
Alfuzosin—Headache—Felbamate—epilepsy syndrome	0.000149	0.000439	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000149	0.000439	CcSEcCtD
Alfuzosin—Flushing—Topiramate—epilepsy syndrome	0.000149	0.000439	CcSEcCtD
Alfuzosin—Cardiac disorder—Topiramate—epilepsy syndrome	0.000149	0.000439	CcSEcCtD
Alfuzosin—Syncope—Gabapentin—epilepsy syndrome	0.000149	0.000439	CcSEcCtD
Alfuzosin—Dizziness—Clonazepam—epilepsy syndrome	0.000149	0.000438	CcSEcCtD
Alfuzosin—Nausea—Vigabatrin—epilepsy syndrome	0.000149	0.000437	CcSEcCtD
Alfuzosin—Vomiting—Zonisamide—epilepsy syndrome	0.000148	0.000436	CcSEcCtD
Alfuzosin—Oedema—Pregabalin—epilepsy syndrome	0.000148	0.000436	CcSEcCtD
Alfuzosin—Asthenia—Lamotrigine—epilepsy syndrome	0.000148	0.000435	CcSEcCtD
Alfuzosin—Dizziness—Phenytoin—epilepsy syndrome	0.000148	0.000435	CcSEcCtD
Alfuzosin—Rash—Zonisamide—epilepsy syndrome	0.000147	0.000433	CcSEcCtD
Alfuzosin—Infection—Pregabalin—epilepsy syndrome	0.000147	0.000433	CcSEcCtD
Alfuzosin—Palpitations—Gabapentin—epilepsy syndrome	0.000147	0.000432	CcSEcCtD
Alfuzosin—Dermatitis—Zonisamide—epilepsy syndrome	0.000147	0.000432	CcSEcCtD
Alfuzosin—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000147	0.000432	CcSEcCtD
Alfuzosin—Nausea—Diazepam—epilepsy syndrome	0.000146	0.00043	CcSEcCtD
Alfuzosin—Loss of consciousness—Gabapentin—epilepsy syndrome	0.000146	0.00043	CcSEcCtD
Alfuzosin—Headache—Zonisamide—epilepsy syndrome	0.000146	0.00043	CcSEcCtD
Alfuzosin—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000146	0.000429	CcSEcCtD
Alfuzosin—Angiopathy—Topiramate—epilepsy syndrome	0.000146	0.000429	CcSEcCtD
Alfuzosin—Pruritus—Lamotrigine—epilepsy syndrome	0.000146	0.000429	CcSEcCtD
Alfuzosin—Shock—Pregabalin—epilepsy syndrome	0.000146	0.000428	CcSEcCtD
Alfuzosin—Somnolence—Valproic Acid—epilepsy syndrome	0.000145	0.000428	CcSEcCtD
Alfuzosin—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000145	0.000427	CcSEcCtD
Alfuzosin—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000145	0.000426	CcSEcCtD
Alfuzosin—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000145	0.000426	CcSEcCtD
Alfuzosin—Tachycardia—Pregabalin—epilepsy syndrome	0.000144	0.000425	CcSEcCtD
Alfuzosin—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000144	0.000424	CcSEcCtD
Alfuzosin—Skin disorder—Pregabalin—epilepsy syndrome	0.000144	0.000423	CcSEcCtD
Alfuzosin—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000143	0.000421	CcSEcCtD
Alfuzosin—Vomiting—Clonazepam—epilepsy syndrome	0.000143	0.000421	CcSEcCtD
Alfuzosin—Vomiting—Phenytoin—epilepsy syndrome	0.000142	0.000418	CcSEcCtD
Alfuzosin—Rash—Clonazepam—epilepsy syndrome	0.000142	0.000417	CcSEcCtD
Alfuzosin—Dermatitis—Clonazepam—epilepsy syndrome	0.000142	0.000417	CcSEcCtD
Alfuzosin—Arthralgia—Gabapentin—epilepsy syndrome	0.000142	0.000417	CcSEcCtD
Alfuzosin—Chest pain—Gabapentin—epilepsy syndrome	0.000142	0.000417	CcSEcCtD
Alfuzosin—Nausea—Felbamate—epilepsy syndrome	0.000142	0.000417	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000141	0.000416	CcSEcCtD
Alfuzosin—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000141	0.000416	CcSEcCtD
Alfuzosin—Fatigue—Valproic Acid—epilepsy syndrome	0.000141	0.000415	CcSEcCtD
Alfuzosin—Dizziness—Carbamazepine—epilepsy syndrome	0.000141	0.000415	CcSEcCtD
Alfuzosin—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000141	0.000415	CcSEcCtD
Alfuzosin—Headache—Clonazepam—epilepsy syndrome	0.000141	0.000414	CcSEcCtD
Alfuzosin—Rash—Phenytoin—epilepsy syndrome	0.000141	0.000414	CcSEcCtD
Alfuzosin—Mental disorder—Topiramate—epilepsy syndrome	0.000141	0.000414	CcSEcCtD
Alfuzosin—Dermatitis—Phenytoin—epilepsy syndrome	0.000141	0.000414	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000141	0.000414	CcSEcCtD
Alfuzosin—Rash—Oxcarbazepine—epilepsy syndrome	0.00014	0.000412	CcSEcCtD
Alfuzosin—Pain—Valproic Acid—epilepsy syndrome	0.00014	0.000412	CcSEcCtD
Alfuzosin—Constipation—Valproic Acid—epilepsy syndrome	0.00014	0.000412	CcSEcCtD
Alfuzosin—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.00014	0.000412	CcSEcCtD
Alfuzosin—Headache—Phenytoin—epilepsy syndrome	0.00014	0.000412	CcSEcCtD
Alfuzosin—Discomfort—Gabapentin—epilepsy syndrome	0.00014	0.000412	CcSEcCtD
Alfuzosin—Headache—Oxcarbazepine—epilepsy syndrome	0.000139	0.00041	CcSEcCtD
Alfuzosin—Nausea—Zonisamide—epilepsy syndrome	0.000139	0.000408	CcSEcCtD
Alfuzosin—Dry mouth—Gabapentin—epilepsy syndrome	0.000138	0.000407	CcSEcCtD
Alfuzosin—Hypotension—Pregabalin—epilepsy syndrome	0.000138	0.000407	CcSEcCtD
Alfuzosin—Dizziness—Lamotrigine—epilepsy syndrome	0.000136	0.000401	CcSEcCtD
Alfuzosin—Oedema—Gabapentin—epilepsy syndrome	0.000136	0.000399	CcSEcCtD
Alfuzosin—Vomiting—Carbamazepine—epilepsy syndrome	0.000135	0.000399	CcSEcCtD
Alfuzosin—Back pain—Topiramate—epilepsy syndrome	0.000135	0.000398	CcSEcCtD
Alfuzosin—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000135	0.000397	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000135	0.000397	CcSEcCtD
Alfuzosin—Infection—Gabapentin—epilepsy syndrome	0.000135	0.000397	CcSEcCtD
Alfuzosin—Rash—Carbamazepine—epilepsy syndrome	0.000134	0.000396	CcSEcCtD
Alfuzosin—Dermatitis—Carbamazepine—epilepsy syndrome	0.000134	0.000395	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000134	0.000394	CcSEcCtD
Alfuzosin—Nausea—Clonazepam—epilepsy syndrome	0.000133	0.000393	CcSEcCtD
Alfuzosin—Headache—Carbamazepine—epilepsy syndrome	0.000133	0.000393	CcSEcCtD
Alfuzosin—Shock—Gabapentin—epilepsy syndrome	0.000133	0.000393	CcSEcCtD
Alfuzosin—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000133	0.000392	CcSEcCtD
Alfuzosin—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.000133	0.000391	CcSEcCtD
Alfuzosin—Nausea—Phenytoin—epilepsy syndrome	0.000133	0.00039	CcSEcCtD
Alfuzosin—Tachycardia—Gabapentin—epilepsy syndrome	0.000132	0.00039	CcSEcCtD
Alfuzosin—Nausea—Oxcarbazepine—epilepsy syndrome	0.000132	0.000388	CcSEcCtD
Alfuzosin—Skin disorder—Gabapentin—epilepsy syndrome	0.000132	0.000388	CcSEcCtD
Alfuzosin—Somnolence—Pregabalin—epilepsy syndrome	0.000132	0.000387	CcSEcCtD
Alfuzosin—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000131	0.000386	CcSEcCtD
Alfuzosin—Vomiting—Lamotrigine—epilepsy syndrome	0.000131	0.000385	CcSEcCtD
Alfuzosin—Urticaria—Valproic Acid—epilepsy syndrome	0.00013	0.000383	CcSEcCtD
Alfuzosin—Rash—Lamotrigine—epilepsy syndrome	0.00013	0.000382	CcSEcCtD
Alfuzosin—Ill-defined disorder—Topiramate—epilepsy syndrome	0.00013	0.000382	CcSEcCtD
Alfuzosin—Dermatitis—Lamotrigine—epilepsy syndrome	0.00013	0.000382	CcSEcCtD
Alfuzosin—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000129	0.000381	CcSEcCtD
Alfuzosin—Headache—Lamotrigine—epilepsy syndrome	0.000129	0.00038	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000128	0.000376	CcSEcCtD
Alfuzosin—Fatigue—Pregabalin—epilepsy syndrome	0.000128	0.000376	CcSEcCtD
Alfuzosin—Hypotension—Gabapentin—epilepsy syndrome	0.000127	0.000373	CcSEcCtD
Alfuzosin—Nausea—Carbamazepine—epilepsy syndrome	0.000127	0.000373	CcSEcCtD
Alfuzosin—Pain—Pregabalin—epilepsy syndrome	0.000127	0.000372	CcSEcCtD
Alfuzosin—Constipation—Pregabalin—epilepsy syndrome	0.000127	0.000372	CcSEcCtD
Alfuzosin—Malaise—Topiramate—epilepsy syndrome	0.000126	0.000371	CcSEcCtD
Alfuzosin—Vertigo—Topiramate—epilepsy syndrome	0.000126	0.00037	CcSEcCtD
Alfuzosin—Syncope—Topiramate—epilepsy syndrome	0.000125	0.000369	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000124	0.000364	CcSEcCtD
Alfuzosin—Palpitations—Topiramate—epilepsy syndrome	0.000124	0.000364	CcSEcCtD
Alfuzosin—Loss of consciousness—Topiramate—epilepsy syndrome	0.000123	0.000362	CcSEcCtD
Alfuzosin—Nausea—Lamotrigine—epilepsy syndrome	0.000122	0.00036	CcSEcCtD
Alfuzosin—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000122	0.000359	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000121	0.000356	CcSEcCtD
Alfuzosin—Somnolence—Gabapentin—epilepsy syndrome	0.000121	0.000355	CcSEcCtD
Alfuzosin—Dyspepsia—Gabapentin—epilepsy syndrome	0.000119	0.000352	CcSEcCtD
Alfuzosin—Arthralgia—Topiramate—epilepsy syndrome	0.000119	0.000351	CcSEcCtD
Alfuzosin—Chest pain—Topiramate—epilepsy syndrome	0.000119	0.000351	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000118	0.000348	CcSEcCtD
Alfuzosin—Discomfort—Topiramate—epilepsy syndrome	0.000118	0.000346	CcSEcCtD
Alfuzosin—Urticaria—Pregabalin—epilepsy syndrome	0.000118	0.000346	CcSEcCtD
Alfuzosin—Asthenia—Valproic Acid—epilepsy syndrome	0.000117	0.000346	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000117	0.000345	CcSEcCtD
Alfuzosin—Fatigue—Gabapentin—epilepsy syndrome	0.000117	0.000344	CcSEcCtD
Alfuzosin—Abdominal pain—Pregabalin—epilepsy syndrome	0.000117	0.000344	CcSEcCtD
Alfuzosin—Dry mouth—Topiramate—epilepsy syndrome	0.000116	0.000343	CcSEcCtD
Alfuzosin—Constipation—Gabapentin—epilepsy syndrome	0.000116	0.000342	CcSEcCtD
Alfuzosin—Pain—Gabapentin—epilepsy syndrome	0.000116	0.000342	CcSEcCtD
Alfuzosin—Pruritus—Valproic Acid—epilepsy syndrome	0.000116	0.000341	CcSEcCtD
Alfuzosin—Oedema—Topiramate—epilepsy syndrome	0.000114	0.000336	CcSEcCtD
Alfuzosin—Infection—Topiramate—epilepsy syndrome	0.000113	0.000334	CcSEcCtD
Alfuzosin—Shock—Topiramate—epilepsy syndrome	0.000112	0.000331	CcSEcCtD
Alfuzosin—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000112	0.00033	CcSEcCtD
Alfuzosin—Nervous system disorder—Topiramate—epilepsy syndrome	0.000112	0.00033	CcSEcCtD
Alfuzosin—Feeling abnormal—Gabapentin—epilepsy syndrome	0.000112	0.000329	CcSEcCtD
Alfuzosin—Thrombocytopenia—Topiramate—epilepsy syndrome	0.000112	0.000329	CcSEcCtD
Alfuzosin—Tachycardia—Topiramate—epilepsy syndrome	0.000111	0.000328	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000111	0.000327	CcSEcCtD
Alfuzosin—Skin disorder—Topiramate—epilepsy syndrome	0.000111	0.000326	CcSEcCtD
Alfuzosin—Hyperhidrosis—Topiramate—epilepsy syndrome	0.00011	0.000325	CcSEcCtD
Alfuzosin—Dizziness—Valproic Acid—epilepsy syndrome	0.000108	0.000319	CcSEcCtD
Alfuzosin—Urticaria—Gabapentin—epilepsy syndrome	0.000108	0.000317	CcSEcCtD
Alfuzosin—Abdominal pain—Gabapentin—epilepsy syndrome	0.000107	0.000316	CcSEcCtD
Alfuzosin—Hypotension—Topiramate—epilepsy syndrome	0.000107	0.000314	CcSEcCtD
Alfuzosin—Asthenia—Pregabalin—epilepsy syndrome	0.000106	0.000312	CcSEcCtD
Alfuzosin—Pruritus—Pregabalin—epilepsy syndrome	0.000105	0.000308	CcSEcCtD
Alfuzosin—Vomiting—Valproic Acid—epilepsy syndrome	0.000104	0.000306	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.000104	0.000306	CcSEcCtD
Alfuzosin—Rash—Valproic Acid—epilepsy syndrome	0.000103	0.000304	CcSEcCtD
Alfuzosin—Dermatitis—Valproic Acid—epilepsy syndrome	0.000103	0.000303	CcSEcCtD
Alfuzosin—Headache—Valproic Acid—epilepsy syndrome	0.000103	0.000302	CcSEcCtD
Alfuzosin—Somnolence—Topiramate—epilepsy syndrome	0.000101	0.000299	CcSEcCtD
Alfuzosin—Diarrhoea—Pregabalin—epilepsy syndrome	0.000101	0.000298	CcSEcCtD
Alfuzosin—Dyspepsia—Topiramate—epilepsy syndrome	0.0001	0.000296	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Topiramate—epilepsy syndrome	9.85e-05	0.00029	CcSEcCtD
Alfuzosin—Fatigue—Topiramate—epilepsy syndrome	9.84e-05	0.00029	CcSEcCtD
Alfuzosin—Dizziness—Pregabalin—epilepsy syndrome	9.78e-05	0.000288	CcSEcCtD
Alfuzosin—Constipation—Topiramate—epilepsy syndrome	9.76e-05	0.000287	CcSEcCtD
Alfuzosin—Pain—Topiramate—epilepsy syndrome	9.76e-05	0.000287	CcSEcCtD
Alfuzosin—Asthenia—Gabapentin—epilepsy syndrome	9.73e-05	0.000287	CcSEcCtD
Alfuzosin—Nausea—Valproic Acid—epilepsy syndrome	9.72e-05	0.000286	CcSEcCtD
Alfuzosin—Pruritus—Gabapentin—epilepsy syndrome	9.6e-05	0.000283	CcSEcCtD
Alfuzosin—Vomiting—Pregabalin—epilepsy syndrome	9.41e-05	0.000277	CcSEcCtD
Alfuzosin—Feeling abnormal—Topiramate—epilepsy syndrome	9.41e-05	0.000277	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Topiramate—epilepsy syndrome	9.33e-05	0.000275	CcSEcCtD
Alfuzosin—Rash—Pregabalin—epilepsy syndrome	9.33e-05	0.000275	CcSEcCtD
Alfuzosin—Dermatitis—Pregabalin—epilepsy syndrome	9.32e-05	0.000274	CcSEcCtD
Alfuzosin—Diarrhoea—Gabapentin—epilepsy syndrome	9.28e-05	0.000273	CcSEcCtD
Alfuzosin—Headache—Pregabalin—epilepsy syndrome	9.27e-05	0.000273	CcSEcCtD
Alfuzosin—Urticaria—Topiramate—epilepsy syndrome	9.07e-05	0.000267	CcSEcCtD
Alfuzosin—Abdominal pain—Topiramate—epilepsy syndrome	9.02e-05	0.000266	CcSEcCtD
Alfuzosin—Dizziness—Gabapentin—epilepsy syndrome	8.97e-05	0.000264	CcSEcCtD
Alfuzosin—Nausea—Pregabalin—epilepsy syndrome	8.79e-05	0.000259	CcSEcCtD
Alfuzosin—Vomiting—Gabapentin—epilepsy syndrome	8.63e-05	0.000254	CcSEcCtD
Alfuzosin—Rash—Gabapentin—epilepsy syndrome	8.55e-05	0.000252	CcSEcCtD
Alfuzosin—Dermatitis—Gabapentin—epilepsy syndrome	8.55e-05	0.000252	CcSEcCtD
Alfuzosin—Headache—Gabapentin—epilepsy syndrome	8.5e-05	0.00025	CcSEcCtD
Alfuzosin—Asthenia—Topiramate—epilepsy syndrome	8.19e-05	0.000241	CcSEcCtD
Alfuzosin—Pruritus—Topiramate—epilepsy syndrome	8.08e-05	0.000238	CcSEcCtD
Alfuzosin—Nausea—Gabapentin—epilepsy syndrome	8.06e-05	0.000237	CcSEcCtD
Alfuzosin—Diarrhoea—Topiramate—epilepsy syndrome	7.81e-05	0.00023	CcSEcCtD
Alfuzosin—Dizziness—Topiramate—epilepsy syndrome	7.55e-05	0.000222	CcSEcCtD
Alfuzosin—Vomiting—Topiramate—epilepsy syndrome	7.26e-05	0.000214	CcSEcCtD
Alfuzosin—Rash—Topiramate—epilepsy syndrome	7.2e-05	0.000212	CcSEcCtD
Alfuzosin—Dermatitis—Topiramate—epilepsy syndrome	7.19e-05	0.000212	CcSEcCtD
Alfuzosin—Headache—Topiramate—epilepsy syndrome	7.15e-05	0.00021	CcSEcCtD
Alfuzosin—Nausea—Topiramate—epilepsy syndrome	6.78e-05	0.0002	CcSEcCtD
Alfuzosin—ADRA1A—GPCR downstream signaling—AVP—epilepsy syndrome	2.03e-05	0.000125	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—OPRM1—epilepsy syndrome	2.01e-05	0.000124	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—QDPR—epilepsy syndrome	2.01e-05	0.000124	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CA4—epilepsy syndrome	2.01e-05	0.000124	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.01e-05	0.000124	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TSC1—epilepsy syndrome	2e-05	0.000123	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PTK2B—epilepsy syndrome	2e-05	0.000123	CbGpPWpGaD
Alfuzosin—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	2e-05	0.000123	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CX3CR1—epilepsy syndrome	1.99e-05	0.000122	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—AGT—epilepsy syndrome	1.97e-05	0.000122	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CX3CL1—epilepsy syndrome	1.95e-05	0.00012	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CHRM2—epilepsy syndrome	1.95e-05	0.00012	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CCR2—epilepsy syndrome	1.95e-05	0.00012	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—BDKRB1—epilepsy syndrome	1.95e-05	0.00012	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—SST—epilepsy syndrome	1.95e-05	0.00012	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NTRK2—epilepsy syndrome	1.95e-05	0.00012	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—CCR5—epilepsy syndrome	1.94e-05	0.00012	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—DUSP6—epilepsy syndrome	1.93e-05	0.000119	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—ADRA2A—epilepsy syndrome	1.91e-05	0.000117	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CDC42—epilepsy syndrome	1.9e-05	0.000117	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCR3—epilepsy syndrome	1.9e-05	0.000117	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.9e-05	0.000117	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PLAT—epilepsy syndrome	1.9e-05	0.000117	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—GABBR1—epilepsy syndrome	1.89e-05	0.000117	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.89e-05	0.000116	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NPY—epilepsy syndrome	1.85e-05	0.000114	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—ATP2A2—epilepsy syndrome	1.85e-05	0.000114	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—AVP—epilepsy syndrome	1.84e-05	0.000113	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CXCL12—epilepsy syndrome	1.83e-05	0.000113	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—BDKRB2—epilepsy syndrome	1.83e-05	0.000113	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—POMC—epilepsy syndrome	1.83e-05	0.000113	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—PRKCB—epilepsy syndrome	1.82e-05	0.000112	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HRH3—epilepsy syndrome	1.82e-05	0.000112	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—IL6ST—epilepsy syndrome	1.82e-05	0.000112	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—AGT—epilepsy syndrome	1.8e-05	0.000111	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CNR1—epilepsy syndrome	1.8e-05	0.000111	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—JUNB—epilepsy syndrome	1.8e-05	0.000111	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PLCB1—epilepsy syndrome	1.79e-05	0.00011	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.79e-05	0.00011	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.79e-05	0.00011	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.79e-05	0.00011	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.79e-05	0.00011	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.79e-05	0.00011	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—OPRM1—epilepsy syndrome	1.79e-05	0.00011	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CXCL2—epilepsy syndrome	1.79e-05	0.00011	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HSPB1—epilepsy syndrome	1.79e-05	0.00011	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCL3—epilepsy syndrome	1.79e-05	0.00011	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CRH—epilepsy syndrome	1.79e-05	0.00011	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—OXT—epilepsy syndrome	1.79e-05	0.00011	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CCR5—epilepsy syndrome	1.76e-05	0.000109	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HTR7—epilepsy syndrome	1.75e-05	0.000108	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—HTR2A—epilepsy syndrome	1.73e-05	0.000106	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—CCR5—epilepsy syndrome	1.72e-05	0.000106	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HBEGF—epilepsy syndrome	1.7e-05	0.000105	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCR3—epilepsy syndrome	1.69e-05	0.000104	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.69e-05	0.000104	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—AKT3—epilepsy syndrome	1.67e-05	0.000103	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.67e-05	0.000103	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TSC1—epilepsy syndrome	1.66e-05	0.000102	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PTK2B—epilepsy syndrome	1.66e-05	0.000102	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—POMC—epilepsy syndrome	1.66e-05	0.000102	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ATP2A2—epilepsy syndrome	1.65e-05	0.000101	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NPY—epilepsy syndrome	1.65e-05	0.000101	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—AGT—epilepsy syndrome	1.64e-05	0.000101	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.64e-05	0.000101	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.64e-05	0.000101	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.64e-05	0.000101	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—ADAM10—epilepsy syndrome	1.63e-05	0.000101	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—CCL2—epilepsy syndrome	1.62e-05	0.0001	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SST—epilepsy syndrome	1.62e-05	9.96e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NTRK2—epilepsy syndrome	1.62e-05	9.96e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCR2—epilepsy syndrome	1.62e-05	9.96e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—DUSP6—epilepsy syndrome	1.6e-05	9.87e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—AGT—epilepsy syndrome	1.6e-05	9.86e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—OXT—epilepsy syndrome	1.59e-05	9.78e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CRH—epilepsy syndrome	1.59e-05	9.78e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HSPB1—epilepsy syndrome	1.59e-05	9.78e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CXCL2—epilepsy syndrome	1.59e-05	9.78e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCL3—epilepsy syndrome	1.59e-05	9.78e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—ADRA2A—epilepsy syndrome	1.58e-05	9.74e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.58e-05	9.71e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PLAT—epilepsy syndrome	1.58e-05	9.7e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CCR5—epilepsy syndrome	1.57e-05	9.65e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—S100B—epilepsy syndrome	1.54e-05	9.51e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—HTR2A—epilepsy syndrome	1.53e-05	9.44e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—SOCS3—epilepsy syndrome	1.53e-05	9.41e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CDC42—epilepsy syndrome	1.52e-05	9.39e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.52e-05	9.37e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.52e-05	9.37e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CXCL12—epilepsy syndrome	1.52e-05	9.36e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—BDKRB2—epilepsy syndrome	1.52e-05	9.36e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—POMC—epilepsy syndrome	1.52e-05	9.35e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PRKCB—epilepsy syndrome	1.51e-05	9.32e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—IL6ST—epilepsy syndrome	1.51e-05	9.28e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—JUNB—epilepsy syndrome	1.49e-05	9.19e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CNR1—epilepsy syndrome	1.49e-05	9.19e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PLCB1—epilepsy syndrome	1.49e-05	9.16e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.48e-05	9.11e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TSC1—epilepsy syndrome	1.48e-05	9.09e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PTK2B—epilepsy syndrome	1.48e-05	9.09e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—AVP—epilepsy syndrome	1.48e-05	9.09e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HTR7—epilepsy syndrome	1.46e-05	8.96e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—AGT—epilepsy syndrome	1.45e-05	8.96e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SST—epilepsy syndrome	1.44e-05	8.84e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCR2—epilepsy syndrome	1.44e-05	8.84e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NTRK2—epilepsy syndrome	1.44e-05	8.84e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.43e-05	8.81e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—DUSP6—epilepsy syndrome	1.42e-05	8.77e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HBEGF—epilepsy syndrome	1.41e-05	8.7e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ADRA2A—epilepsy syndrome	1.41e-05	8.65e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PLAT—epilepsy syndrome	1.4e-05	8.62e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HES1—epilepsy syndrome	1.4e-05	8.6e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.39e-05	8.57e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—AKT3—epilepsy syndrome	1.39e-05	8.54e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—POMC—epilepsy syndrome	1.38e-05	8.49e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—FYN—epilepsy syndrome	1.36e-05	8.36e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.36e-05	8.35e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.36e-05	8.35e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—ADAM10—epilepsy syndrome	1.35e-05	8.34e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—H2AFX—epilepsy syndrome	1.35e-05	8.33e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MEF2C—epilepsy syndrome	1.35e-05	8.32e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—BDKRB2—epilepsy syndrome	1.35e-05	8.32e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CXCL12—epilepsy syndrome	1.35e-05	8.32e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CCL2—epilepsy syndrome	1.35e-05	8.31e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—POMC—epilepsy syndrome	1.35e-05	8.3e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PRKCB—epilepsy syndrome	1.34e-05	8.28e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—IL6ST—epilepsy syndrome	1.34e-05	8.24e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—JUNB—epilepsy syndrome	1.33e-05	8.16e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CNR1—epilepsy syndrome	1.33e-05	8.16e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PLCB1—epilepsy syndrome	1.32e-05	8.13e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—YWHAZ—epilepsy syndrome	1.3e-05	8.04e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.29e-05	7.97e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.29e-05	7.97e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HTR7—epilepsy syndrome	1.29e-05	7.96e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NGF—epilepsy syndrome	1.29e-05	7.95e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—S100B—epilepsy syndrome	1.28e-05	7.89e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SOCS3—epilepsy syndrome	1.27e-05	7.81e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.27e-05	7.8e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CDC42—epilepsy syndrome	1.27e-05	7.79e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HBEGF—epilepsy syndrome	1.26e-05	7.73e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CCR5—epilepsy syndrome	1.26e-05	7.73e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.24e-05	7.64e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AKT3—epilepsy syndrome	1.23e-05	7.59e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HTR2A—epilepsy syndrome	1.23e-05	7.56e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—AVP—epilepsy syndrome	1.23e-05	7.55e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—POMC—epilepsy syndrome	1.22e-05	7.54e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.22e-05	7.49e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ADAM10—epilepsy syndrome	1.2e-05	7.41e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CCL2—epilepsy syndrome	1.2e-05	7.38e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.19e-05	7.36e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TSC2—epilepsy syndrome	1.17e-05	7.19e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—AGT—epilepsy syndrome	1.17e-05	7.18e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HES1—epilepsy syndrome	1.16e-05	7.14e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—APOE—epilepsy syndrome	1.14e-05	7.03e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—S100B—epilepsy syndrome	1.14e-05	7.01e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SOCS3—epilepsy syndrome	1.13e-05	6.94e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—FYN—epilepsy syndrome	1.13e-05	6.94e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CDC42—epilepsy syndrome	1.12e-05	6.92e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—H2AFX—epilepsy syndrome	1.12e-05	6.91e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MEF2C—epilepsy syndrome	1.12e-05	6.9e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—KDR—epilepsy syndrome	1.12e-05	6.89e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.12e-05	6.88e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AVP—epilepsy syndrome	1.09e-05	6.7e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.08e-05	6.68e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—YWHAZ—epilepsy syndrome	1.08e-05	6.67e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PRKCB—epilepsy syndrome	1.08e-05	6.63e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IL6ST—epilepsy syndrome	1.07e-05	6.61e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NGF—epilepsy syndrome	1.07e-05	6.6e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCR5—epilepsy syndrome	1.04e-05	6.42e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HES1—epilepsy syndrome	1.03e-05	6.34e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HTR2A—epilepsy syndrome	1.02e-05	6.28e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—FYN—epilepsy syndrome	1e-05	6.16e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—H2AFX—epilepsy syndrome	9.97e-06	6.14e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MEF2C—epilepsy syndrome	9.95e-06	6.13e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—POMC—epilepsy syndrome	9.81e-06	6.04e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	9.81e-06	6.04e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	9.81e-06	6.04e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TSC2—epilepsy syndrome	9.68e-06	5.96e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—AGT—epilepsy syndrome	9.67e-06	5.96e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—YWHAZ—epilepsy syndrome	9.62e-06	5.92e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CCL2—epilepsy syndrome	9.6e-06	5.91e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NGF—epilepsy syndrome	9.51e-06	5.86e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—APOE—epilepsy syndrome	9.48e-06	5.84e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—KDR—epilepsy syndrome	9.28e-06	5.72e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCR5—epilepsy syndrome	9.25e-06	5.7e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HTR2A—epilepsy syndrome	9.05e-06	5.58e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PRKCB—epilepsy syndrome	8.94e-06	5.5e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IL6ST—epilepsy syndrome	8.9e-06	5.48e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—FGF2—epilepsy syndrome	8.67e-06	5.34e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TSC2—epilepsy syndrome	8.6e-06	5.3e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AGT—epilepsy syndrome	8.59e-06	5.29e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APOE—epilepsy syndrome	8.42e-06	5.18e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	8.25e-06	5.08e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—POMC—epilepsy syndrome	8.14e-06	5.01e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—RELA—epilepsy syndrome	8.05e-06	4.96e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	7.99e-06	4.92e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCL2—epilepsy syndrome	7.97e-06	4.91e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	7.94e-06	4.89e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	7.91e-06	4.87e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MTOR—epilepsy syndrome	7.9e-06	4.86e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	7.79e-06	4.8e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	7.74e-06	4.77e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—AKT1—epilepsy syndrome	7.33e-06	4.51e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CASP3—epilepsy syndrome	7.26e-06	4.47e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	7.23e-06	4.45e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	7.2e-06	4.43e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	7.08e-06	4.36e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—JUN—epilepsy syndrome	7.05e-06	4.34e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	6.99e-06	4.3e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MMP9—epilepsy syndrome	6.86e-06	4.23e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	6.68e-06	4.12e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—AKT1—epilepsy syndrome	6.66e-06	4.1e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	6.65e-06	4.1e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—BCHE—epilepsy syndrome	6.62e-06	4.08e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	6.55e-06	4.04e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	6.39e-06	3.94e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—SRC—epilepsy syndrome	6.33e-06	3.9e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	6.32e-06	3.89e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	6.25e-06	3.85e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—TH—epilepsy syndrome	6.23e-06	3.84e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—VEGFA—epilepsy syndrome	6.16e-06	3.8e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	6.08e-06	3.75e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	6.03e-06	3.71e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	5.94e-06	3.66e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	5.85e-06	3.61e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	5.82e-06	3.59e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	5.7e-06	3.51e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	5.52e-06	3.4e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	5.4e-06	3.33e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	5.35e-06	3.3e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	5.25e-06	3.23e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	5.2e-06	3.2e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	5.2e-06	3.2e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CAT—epilepsy syndrome	5.13e-06	3.16e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	5.12e-06	3.15e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	5.06e-06	3.12e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	4.99e-06	3.07e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	4.91e-06	3.02e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	4.66e-06	2.87e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GPX1—epilepsy syndrome	4.64e-06	2.86e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	4.54e-06	2.8e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—AGT—epilepsy syndrome	4.07e-06	2.51e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.99e-06	2.45e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—AKT1—epilepsy syndrome	3.93e-06	2.42e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—POMC—epilepsy syndrome	3.42e-06	2.11e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	3.26e-06	2.01e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ALB—epilepsy syndrome	3.12e-06	1.92e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	2.9e-06	1.79e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.73e-06	1.68e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.37e-06	8.45e-06	CbGpPWpGaD
